High Signal Podcasts Evidence ledger
Method
Browse
← Back to evidence

Evidence receipt / belief

Published · transcript-backed

David Rosenthal: belief

22 Jan 2024 Acquired Novo Nordisk (Ozempic)

“I think that's how she phrases it too, when she describes it as protecting the molecule.”

— David Rosenthal

Source trail

Everything needed to verify it.

Speaker
David Rosenthal
Attribution
Verified speaker
Claim type
belief
Recorded
22 Jan 2024
Publisher
Acquired

Transcript context

…The mechanism by which it does this is totally fascinating. You mentioned that the fatty acid gets attached to the GLP-1 to create this GLP-1 analogue. The way it basically works is it has to bind in a very specific location, such that the receptor is not blocked, but it is grafted onto that molecule so they can travel together. The fatty acids then make it so the GLP-1 can bind to another protein, which I believe is pronounced albumin, which is this really large protein that is very common in the bloodstream. It protects the GLP 1 molecule from the degradation by enzymes, and it protects it from being quickly cleared in the kidney, because that bound molecule is now too complex, too large to be filtered. It makes it like a big truck bouncing down a small highway in that the molecule is protected. Yeah. I think that's how she phrases it too, when she describes it as protecting the molecule. Yup. The fatty acid makes it big and stick to stuff.…

Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.

Search evidence